JAMA (Journal of the American Medical Association): post #6565 — TG.ME

Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction
https://jamanetwork.com/journals/jama/fullarticle/2853274

This prospective randomized open, blinded end-point adjudication study examines evolocumab as first-line therapy vs standard care in patients with high-risk acute myocardial infarction undergoing percutaneous coronary intervention.
❤1
August 29, 2026 426 2